Flexion Therapeutics

IPO

Local therapies for musculoskeletal conditions

Flexion Therapeutics was founded in 2007, is headquartered in Burlington, United States, lists 51–200 employees, and has $53.0M in recorded funding across 2 rounds.

Employees
51–200
Founded
2007
Business Model
B2B
Total Funding
$53.0M
Last Round
$33.0M Series AJan 2010
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Flexion Therapeutics (NASDAQ: FLXN) was a biopharmaceutical company focused on the discovery, development, and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, with a primary focus on osteoarthritis pain. The company developed ZILRETTA, an extended-release corticosteroid injection for osteoarthritis knee pain. Founded in 2007 and headquartered in Burlington, Massachusetts, Flexion was acquired by Pacira BioSciences in November 2021 for approximately $630 million, strengthening Pacira's non-opioid pain management portfolio.

Summary

Flexion Therapeutics is a Biotech company based in Burlington, United States, founded in 2007. It lists 51–200 employees. It has raised $53.0M in total across 2 rounds, most recently a $33.0M Series A round in Jan 2010. Investors include Versant Ventures, 5AM Ventures and Sofinnova Partners.

Funding & Exit History

IPOFeb 2014
$74.8M

Sign up to see all 3 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Flexion Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/flexion-therapeutics"><img src="https://indexed.vc/api/badge/company/flexion-therapeutics" alt="Flexion Therapeutics on Indexed.vc" width="260" height="76" /></a>